Tag archive for ‘KIte Pharma in CAR-T’
Kite Pharma Part 3: A Detailed Analysis of the Design of the All-Important ZUMA-1 Trial
Report Overview This is the third part of the series of reports that I have written on Kite Pharmaceuticals. I have chosen to publish smaller, more digestible parts of an extensive research analysis on Kite instead of one huge report. I hope this will make it easier for subscribers to work their way through what […]